The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

You can track the start of spring and the phases of the moon—or you can turn to a formula by mathematician Carl Friedrich ...

As droughts worsen and freshwater grows scarce, desalination is expanding rapidly. More than 20,000 plants now convert ...

OpenAI is shutting down Sora, its controversial and disruptive text-to-video generative AI model. The end of Sora also ends ...

Orforglipron is the second daily weight-loss pill to hit the market. The first was the Wegovy pill, from Novo Nordisk, which ...

It showcases exactly what is possible when material innovation and product development are engineered in tandem from the start. Designed for the unpredictability of modern life, the collection ...

Keeping your filament safely away from moisture exposure is one of the most crucial aspects of getting a good 3D print, with ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

Although AI is not intentionally biased, it can inherit biases from the data fed into it, learning and repeating them until ...

The Hull-White model is a key tool in pricing interest rate derivatives. It assumes normally distributed short rates with ...

The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form ...

SolveSpace is a free, open-source CAD tool that fits in 1MB, with a full 3D solver, parametric sketching, and a browser-based ...